Omega Sets Date for Third Quarter Earnings Release and Conference Call
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 03 2025
0mins
Should l Buy OHI?
Source: Newsfilter
Earnings Release Announcement: Omega Healthcare Investors, Inc. will release its earnings results for Q3 2025 on October 30, 2025, after market close, followed by a conference call on October 31, 2025, at 10 a.m. ET.
Accessing the Conference Call: Investors can join the call via the company's website or by telephone, with specific dial-in numbers provided, and a replay will be available for two weeks post-call.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OHI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OHI
Wall Street analysts forecast OHI stock price to rise
9 Analyst Rating
4 Buy
5 Hold
0 Sell
Moderate Buy
Current: 45.720
Low
42.00
Averages
46.44
High
50.00
Current: 45.720
Low
42.00
Averages
46.44
High
50.00
About OHI
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through a single segment, which invests in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). Its core portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. The Company's portfolio of real estate investments includes over 1,026 healthcare facilities, located in 42 states and the United Kingdom that are operated by 87 third-party operators.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Oversold Stock List: The Relative Strength Index (RSI) screening highlights Sysco Corporation (SYY) at the top with an RSI of 24, indicating significant oversold signals and a market capitalization of $34.11 billion, suggesting potential undervaluation and rebound opportunities.
- Sector Distribution: Following closely is Boston Scientific Corporation (BSX) with an RSI of 25 and a market cap of $93.26 billion, reflecting intense selling pressure across sectors such as healthcare and consumer staples, which may present value investment opportunities for investors.
- Other Notable Oversold Stocks: McCormick & Company (MKC), Cintas Corporation (CTAS), and Universal Health Services (UHS) rank in the top five with RSI values of 26 and 27, and market caps of $13.54 billion, $67.66 billion, and $10.93 billion respectively, highlighting their vulnerability in the current market environment.
- Market Pressure Analysis: All stocks in the top ten list maintain an RSI below 30, indicating high selling pressure across sectors including medical facilities, retail, and real estate, prompting investors to monitor these oversold stocks for potential rebound opportunities amidst market volatility.
See More
- Asset Sales and Dividend Cuts: Medical Properties Trust faced financial distress due to high leverage used for expansion, leading to asset sales and two dividend cuts, resulting in a 75% decline in stock price from its 2020 peak, highlighting the company's vulnerability in managing tenant rent payment issues.
- Improved Financial Foundation: Despite the challenging period, Medical Properties Trust has significantly improved its financial foundation through asset sales and dividend cuts, recently announcing a 12.5% dividend increase, which, although only a penny per share, symbolizes the company's belief that the worst is behind it.
- Future Outlook: With the company's financial situation improving, long-term investors may consider holding onto the stock for potential recovery over the coming years, even though a quick rebound should not be expected given the current stock price challenges.
- Tax Strategy Advice: For investors sitting on large paper losses, realizing those losses to offset gains elsewhere may be a prudent strategy, as it can reduce tax liabilities and free up capital for investment in stocks with better dividend histories.
See More
- Financial Flexibility Issues: Medical Properties Trust faced significant financial flexibility challenges due to tenants' inability to pay rent, resulting in a roughly 75% decline in stock price from 2022 highs, raising concerns about its future viability.
- Dividend Cuts and Asset Sales: To navigate its difficulties, the REIT underwent two dividend cuts and sold some assets, albeit at a loss, but these actions have helped it gradually recover from its troubles.
- Dividend and Buyback Announcement: The REIT announced a 12.5% increase in dividends for late 2025, translating to a mere penny per share, alongside a $150 million stock buyback plan, indicating a positive outlook for the company's future.
- Investor Risk Assessment: While the dividend yield is nearly 6%, above the REIT average, the two dividend cuts may raise concerns for conservative investors about the company's stability, suggesting they might consider other more stable REIT options.
See More
- Dividend Recovery Signal: Medical Properties Trust, after two dividend cuts, announced a quarterly dividend increase from $0.08 to $0.09 per share at the end of 2025, indicating a gradual recovery in financial health despite the modest increase of just one cent.
- Asset Sales and Financial Adjustments: To address issues with tenant payment capabilities, the REIT had to sell some assets and write off uncollectible rents, which, while causing short-term losses, helped improve the company's financial flexibility.
- Stock Buyback Plan: The REIT also announced a $150 million stock buyback plan aimed at boosting shareholder confidence and enhancing stock price, reflecting the company's optimistic outlook for future growth.
- Investor Confidence Rebuilding: Although the REIT's stock is down approximately 75% from its 2022 highs, investor confidence is beginning to recover as the business stabilizes, particularly with a dividend yield nearing 6%, though caution is still advised regarding risks.
See More
- Strong Market Demand: As the U.S. population ages, the demand for long-term care services accelerates, with healthcare REITs showing an 8.5% return in 2025, positioning them among the stronger-performing sectors in real estate, reflecting stable demand drivers and long-term occupancy visibility.
- Successful Acquisition Strategy: Strawberry Fields REIT acquired nine skilled nursing facilities in Missouri for $59 million, leasing them to Tide Group under a long-term agreement, which is expected to increase annual rents by $5.5 million, demonstrating growth potential in a constrained supply market.
- Diversified Asset Portfolio: Strawberry Fields owns 143 healthcare facilities across 10 states, providing over 15,600 licensed beds, which helps the company mitigate risks across various operating environments while focusing on investments in post-acute care real estate.
- Stable Dividend Distribution: In an uncertain economic environment, Strawberry Fields announced a cash dividend of $0.16 per share for Q4 2025, with an annual yield of approximately 5%, indicating the company's ability to support stable cash flow and shareholder returns while maintaining a low payout ratio.
See More










